Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China

被引:1
|
作者
Wang, Le [1 ]
Jiang, Zhao [1 ]
Chen, Bei-Bei [1 ]
Wang, Cheng-Tai [2 ]
Wang, Jin-Xiang [1 ]
Bai, Jie [1 ]
Wang, Bi [1 ]
Jin, Lang [1 ]
Zhang, Wen Juan [1 ]
Deng, Yan-Chun [1 ]
Zhao, Gang [1 ]
Dang, Jing-Xia [3 ]
Wang, Dong [4 ]
Jia, Shan-Shan [4 ]
Wang, Tian-Cheng [5 ]
Jia, Fei-Yong [6 ]
Zhang, Li [7 ]
Liu, Yong-Hong [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, 127 West ChangLe Rd, Xian 710032, Peoples R China
[2] Baoji Tradit Chinese Med Hosp, Dept Neurol, Baoji, Peoples R China
[3] Xi An Jiao Tong Univ, Dept Neurol, Affiliated Hosp 1, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Xian Pediat Hosp, Dept Neurol, Xian, Peoples R China
[5] Lanzhou Univ, Hosp 2, Dept Neurol, Lanzhou, Peoples R China
[6] Jilin Univ, Hosp 1, Dept Pediat Neurol & Neurorehabil, Changchun, Peoples R China
[7] Xian Gaoxin Hosp, Dept Neurol, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
Electroclinical characteristics; Photoparoxysmal responses; Generalized spike-wave discharge; Valproate; VALPROIC ACID; OPEN-LABEL; TOPIRAMATE; EFFICACY; LEVETIRACETAM; EXACERBATION; EPIDEMIOLOGY; LAMOTRIGINE; JME;
D O I
10.1016/j.yebeh.2016.07.011
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objective: The objective of this study was to assess the electroclinical aspects and treatment of Han patients with juvenile myoclonic epilepsy (JME) in northern China. Methods: One hundred fifty-six outpatients with JME from six epilepsy centers, between January 2011 and June 2012, were followed up for at least two years. They underwent twenty-four-hour video-EEG recording. Brain imaging was performed using magnetic resonance imaging (MRI). Clinical aspects, electroencephalographic (EEG) features, and antiepileptic drugs (AEDs) received were reviewed. Results: Generalized tonic-clonic seizures (GTCS) were found in 150/156 patients. Delay of diagnosis was 4.60 +/- 9.92 years. Photosensitivity was more common in eye closure condition during IPS in patients with JME; in addition, patients with JME with myoclonic seizures (MS) and GTCS as seizure types were likely to present photoparoxysmal responses (PPRs). The 82 nontreated patients showed a median latency to first interictal or ictal generalized spike-wave discharge (GSWD) of 50 min (IQR: 22-102 min). The first GSWDs were recorded in 63%, 76%, 90%, and 98% patients within one, two, three, and 4 h, respectively; only 2% of patients had first GSWDs after 4 h. One hundred eleven patients (111/156) chose extended-release valproate (VPA) at daily doses <= 1000 mg. The percentages of seizure-free patients among MS, GTCS, and absence seizure (AS) groups were 88.3%, 99.0%, and 94.9%, respectively. Conclusion: Photoparoxysmal responses were more common in patients with JME with MS and GTCS and rare in patients with JME with MS and AS in northern Chinese Han patients. Most patients with JME in northern China chose VPA as first therapeutic choice, and low dose (500 to 1000 mg daily) of extended-release VPA may be an optimal choice for them. Video-EEG monitoring for at least 4 h may be helpful in detecting the first interictal or ictal GSWD in patients with potential JME. Moreover, video-EEG monitoring performed at about 9 o'clock in the morning with patients in the awake state might be useful to find the first GSWD. For JME diagnosis, Class II criteria are more helpful than Class I counterparts, the latter yielding more missed diagnoses. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:204 / 208
页数:5
相关论文
共 40 条
  • [1] Challenges in the Treatment of Juvenile Myoclonic Epilepsy in Female Patients
    Guzin, Yigithan
    Bozkaya-Yilmaz, Sema
    Basarir, Gunce
    Olgac-Dundar, Nihal
    JOURNAL OF PEDIATRIC EPILEPSY, 2024, 13 (03) : 71 - 74
  • [2] The first line of therapy in a girl with juvenile myoclonic epilepsy: Should it be valproate or a new agent?
    Montouris, Georgia
    Abou-Khalil, Bassel
    EPILEPSIA, 2009, 50 : 16 - 20
  • [3] Clinical aspects of juvenile myoclonic epilepsy
    Genton, Pierre
    Thomas, Pierre
    Trenite, Dorothee G. A. Kasteleijn-Nolst
    Medina, Marco Tulio
    Salas-Puig, Javier
    EPILEPSY & BEHAVIOR, 2013, 28 : S8 - S14
  • [4] Methsuximide therapy of juvenile myoclonic epilepsy
    Hurst, DL
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1996, 5 (01): : 47 - 50
  • [5] Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients
    Zhang, Yingying
    Chen, Jiani
    Ren, Jiechuan
    Liu, Wenyu
    Yang, Tianhua
    Zhou, Dong
    EPILEPSIA OPEN, 2019, 4 (02) : 302 - 308
  • [6] Sleep architecture in patients with Juvenile Myoclonic Epilepsy
    Mekky, Jaidaa F.
    Elbhrawy, Sonia M.
    Boraey, Mohamed F.
    Omar, Horeya M.
    SLEEP MEDICINE, 2017, 38 : 116 - 121
  • [7] Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME)
    Asadi-Pooya, Ali A.
    Hashemzehi, Zabihollah
    Emami, Mehrdad
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (10): : 889 - 891
  • [8] Antiseizure Medications Withdrawal Seizures in Patients with Juvenile Myoclonic Epilepsy
    Hofi, Elyasaf
    Medvedovsky, Mordekhay
    Nassar, Mais
    Levy, Naomi Khana
    Eyal, Sara
    Ekstein, Dana
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (04): : 253 - 257
  • [9] Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate
    de Araujo Filho, Gerardo M.
    Pascalicchio, Tatiana F.
    Lin, Katia
    Sousa, Patricia S.
    Yacubian, Elza M. T.
    EPILEPSY & BEHAVIOR, 2006, 8 (03) : 606 - 609
  • [10] JUVENILE MYOCLONIC EPILEPSY: MORE TRIALS ARE NEEDED TO GUIDE THERAPY
    Abou-Khalil, Bassel W.
    EPILEPSY CURRENTS, 2009, 9 (01) : 10 - 11